Global Dog Vaccines Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 118

Report ID: 15013

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
The global Dog Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dog Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Dog Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dog Vaccines in these regions.
This research report categorizes the global Dog Vaccines market by top players/brands, region, type and end user. This report also studies the global Dog Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)

Market size by Product
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Market size by End User
<6 Months
≥ Months

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Dog Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dog Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dog Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dog Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Dog Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dog Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Dog Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dog Vaccines Market Size Growth Rate by Product
1.4.2 Attenuated Live Vaccines
1.4.3 Conjugate Vaccines
1.4.4 Inactivated Vaccines
1.4.5 Subunit Vaccines
1.4.6 Toxoid Vaccines
1.4.7 DNA Vaccines
1.4.8 Recombinant Vaccines
1.5 Market by End User
1.5.1 Global Dog Vaccines Market Size Growth Rate by End User
1.5.2 <6 Months
1.5.3 ≥ Months
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Dog Vaccines Market Size
2.1.1 Global Dog Vaccines Revenue 2014-2025
2.1.2 Global Dog Vaccines Sales 2014-2025
2.2 Dog Vaccines Growth Rate by Regions
2.2.1 Global Dog Vaccines Sales by Regions
2.2.2 Global Dog Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Dog Vaccines Sales by Manufacturers
3.1.1 Dog Vaccines Sales by Manufacturers
3.1.2 Dog Vaccines Sales Market Share by Manufacturers
3.1.3 Global Dog Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Dog Vaccines Revenue by Manufacturers
3.2.1 Dog Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Dog Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Dog Vaccines Price by Manufacturers
3.4 Dog Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Dog Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dog Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Dog Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Dog Vaccines Sales by Product
4.2 Global Dog Vaccines Revenue by Product
4.3 Dog Vaccines Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Dog Vaccines Breakdown Data by End User

6 North America
6.1 North America Dog Vaccines by Countries
6.1.1 North America Dog Vaccines Sales by Countries
6.1.2 North America Dog Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dog Vaccines by Product
6.3 North America Dog Vaccines by End User

7 Europe
7.1 Europe Dog Vaccines by Countries
7.1.1 Europe Dog Vaccines Sales by Countries
7.1.2 Europe Dog Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dog Vaccines by Product
7.3 Europe Dog Vaccines by End User

8 Asia Pacific
8.1 Asia Pacific Dog Vaccines by Countries
8.1.1 Asia Pacific Dog Vaccines Sales by Countries
8.1.2 Asia Pacific Dog Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Dog Vaccines by Product
8.3 Asia Pacific Dog Vaccines by End User

9 Central & South America
9.1 Central & South America Dog Vaccines by Countries
9.1.1 Central & South America Dog Vaccines Sales by Countries
9.1.2 Central & South America Dog Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Dog Vaccines by Product
9.3 Central & South America Dog Vaccines by End User

10 Middle East and Africa
10.1 Middle East and Africa Dog Vaccines by Countries
10.1.1 Middle East and Africa Dog Vaccines Sales by Countries
10.1.2 Middle East and Africa Dog Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Dog Vaccines by Product
10.3 Middle East and Africa Dog Vaccines by End User

11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Company Details
11.1.2 Company Business Overview
11.1.3 Bayer Healthcare Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer Healthcare Dog Vaccines Products Offered
11.1.5 Bayer Healthcare Recent Development
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Company Details
11.2.2 Company Business Overview
11.2.3 Vetoquinol S.A Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Vetoquinol S.A Dog Vaccines Products Offered
11.2.5 Vetoquinol S.A Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Company Business Overview
11.3.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Boehringer Ingelheim Dog Vaccines Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Ceva
11.4.1 Ceva Company Details
11.4.2 Company Business Overview
11.4.3 Ceva Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Ceva Dog Vaccines Products Offered
11.4.5 Ceva Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Business Overview
11.5.3 Eli Lilly Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eli Lilly Dog Vaccines Products Offered
11.5.5 Eli Lilly Recent Development
11.6 Heska Co.
11.6.1 Heska Co. Company Details
11.6.2 Company Business Overview
11.6.3 Heska Co. Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Heska Co. Dog Vaccines Products Offered
11.6.5 Heska Co. Recent Development
11.7 Merck Animal Health
11.7.1 Merck Animal Health Company Details
11.7.2 Company Business Overview
11.7.3 Merck Animal Health Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck Animal Health Dog Vaccines Products Offered
11.7.5 Merck Animal Health Recent Development
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Company Details
11.8.2 Company Business Overview
11.8.3 Merial (Sanofi) Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Merial (Sanofi) Dog Vaccines Products Offered
11.8.5 Merial (Sanofi) Recent Development
11.9 Virbac
11.9.1 Virbac Company Details
11.9.2 Company Business Overview
11.9.3 Virbac Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Virbac Dog Vaccines Products Offered
11.9.5 Virbac Recent Development
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Company Details
11.10.2 Company Business Overview
11.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Zoetis (Pfizer) Dog Vaccines Products Offered
11.10.5 Zoetis (Pfizer) Recent Development

12 Future Forecast
12.1 Dog Vaccines Market Forecast by Regions
12.1.1 Global Dog Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Dog Vaccines Revenue Forecast by Regions 2019-2025
12.2 Dog Vaccines Market Forecast by Product
12.2.1 Global Dog Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Dog Vaccines Revenue Forecast by Product 2019-2025
12.3 Dog Vaccines Market Forecast by End User
12.4 North America Dog Vaccines Forecast
12.5 Europe Dog Vaccines Forecast
12.6 Asia Pacific Dog Vaccines Forecast
12.7 Central & South America Dog Vaccines Forecast
12.8 Middle East and Africa Dog Vaccines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dog Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer